The company said that it now intends to advance Z-1018 into the next part of the study in adults 70 years of age and older in ...

A study published this week in the peer-reviewed journal Scientific Reports examined the long-term impacts of having shingles ...

Dynavax's Z-1018 shingles vaccine matched Shingrix in immune response with fewer side effects, advancing to Phase 2 in older adults in 2025.

Shares of Dynavax rose after the company released positive results from a trial of its shingles vaccine tested against current Shingles vaccine Shingrix. The stock was up 6.7% to $11.12 but is still ...

Modern homeowners are becoming increasingly conscious of energy use—not just for cost savings, but also for environmental responsibility. One of the most overlooked factors influencing home efficiency ...

Dynavax (DVAX) stock gains as the company's Z-1018 shingles shot shows immune response comparable to GSK's (GSK) Shingrix vaccine in a Phase 1/2 trial. Read more here.

Steve Clisset, a longtime roofer based near Paonia, has been selected to fabricate and install custom metal shingles for a historic restoration project at Fort Yellowstone. His trademarked product, ...

Dynavax’s lofty ambition to snatch Shingrix’s crown got off to a promising start after the biopharma’s investigational shingles vaccine held its own against GSK’s mainstay in the first part of a phase ...

Dynavax Technologies said on Thursday its experimental shingles vaccine generated a similar immune response as GSK's blockbuster shot Shingrix, while showing a better safety profile, in ...

The Insurance Institute for Business and Home Safety in rural Chester County simulates strong hurricanes to test sample ...

One Redditor shared how their solar panel installation will pay for itself in 10 years — and how to use Tesla's backup power.

In rare instances, the homeowner will simply strip the current siding and trim off the house to start new, but this is costly ...